| First Author | Grosse L | Year | 2020 |
| Journal | Cell Metab | Volume | 32 |
| Issue | 1 | Pages | 87-99.e6 |
| PubMed ID | 32485135 | Mgi Jnum | J:296551 |
| Mgi Id | MGI:6469022 | Doi | 10.1016/j.cmet.2020.05.002 |
| Citation | Grosse L, et al. (2020) Defined p16(High) Senescent Cell Types Are Indispensable for Mouse Healthspan. Cell Metab 32(1):87-99.e6 |
| abstractText | The accumulation of senescent cells can drive many age-associated phenotypes and pathologies. Consequently, it has been proposed that removing senescent cells might extend lifespan. Here, we generated two knockin mouse models targeting the best-characterized marker of senescence, p16(Ink4a). Using a genetic lineage tracing approach, we found that age-induced p16(High) senescence is a slow process that manifests around 10-12 months of age. The majority of p16(High) cells were vascular endothelial cells mostly in liver sinusoids (LSECs), and to lesser extent macrophages and adipocytes. In turn, continuous or acute elimination of p16(High) senescent cells disrupted blood-tissue barriers with subsequent liver and perivascular tissue fibrosis and health deterioration. Our data show that senescent LSECs are not replaced after removal and have important structural and functional roles in the aging organism. In turn, delaying senescence or replacement of senescent LSECs could represent a powerful tool in slowing down aging. |
